Carderock Capital Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-800
| Closed | -$63.3K | – | 104 |
|
|
2025
Q2 | $63.3K | Buy |
+800
| New | +$63.6K | 0.02% | 106 |
|
|
2023
Q2 | – | Sell |
-975
| Closed | -$104K | – | 97 |
|
|
2023
Q1 | $104K | Buy |
+975
| New | +$105K | 0.04% | 76 |
|
|
2021
Q4 | – | Sell |
-2,050
| Closed | -$154K | – | 121 |
|
|
2021
Q3 | $154K | Sell |
2,050
-551
| -21% | -$41.9K | 0.04% | 82 |
|
|
2021
Q2 | $202K | Sell |
2,601
-492
| -16% | -$36.6K | 0.06% | 77 |
|
|
2021
Q1 | $227K | Sell |
3,093
-758
| -20% | -$55.9K | 0.07% | 75 |
|
|
2020
Q4 | $301K | Sell |
3,851
-629
| -14% | -$48.1K | 0.09% | 67 |
|
|
2020
Q3 | $355K | Sell |
4,480
-680
| -13% | -$53.3K | 0.12% | 63 |
|
|
2020
Q2 | $381K | Hold |
5,160
| – | – | 0.14% | 62 |
|
|
2020
Q1 | $379K | Hold |
5,160
| – | – | 0.17% | 56 |
|
|
2019
Q4 | $448K | Sell |
5,160
-629
| -11% | -$51.7K | 0.15% | 66 |
|
|
2019
Q3 | $465K | Buy |
5,789
+497
| +9% | +$39.8K | 0.17% | 61 |
|
|
2019
Q2 | $423K | Sell |
5,292
-524
| -9% | -$40.1K | 0.16% | 62 |
|
|
2019
Q1 | $462K | Hold |
5,816
| – | – | 0.19% | 62 |
|
|
2018
Q4 | $424K | Sell |
5,816
-158
| -3% | -$11.2K | 0.22% | 62 |
|
|
2018
Q3 | $404K | Hold |
5,974
| – | – | 0.16% | 71 |
|
|
2018
Q2 | $346K | Sell |
5,974
-366
| -6% | -$20.6K | 0.15% | 71 |
|
|
2018
Q1 | $330K | Hold |
6,340
| – | – | 0.15% | 70 |
|
|
2017
Q4 | $340K | Sell |
6,340
-113
| -2% | -$6.26K | 0.15% | 71 |
|
|
2017
Q3 | $394K | Sell |
6,453
-421
| -6% | -$25.5K | 0.18% | 66 |
|
|
2017
Q2 | $420K | Sell |
6,874
-315
| -4% | -$19.2K | 0.19% | 68 |
|
|
2017
Q1 | $436K | Sell |
7,189
-1,354
| -16% | -$82.1K | 0.2% | 68 |
|
|
2016
Q4 | $480K | Hold |
8,543
| – | – | 0.24% | 64 |
|
|
2016
Q3 | $509K | Hold |
8,543
| – | – | 0.25% | 66 |
|
|
2016
Q2 | $470K | Buy |
8,543
+629
| +8% | +$33.5K | 0.25% | 64 |
|
|
2016
Q1 | $400K | Sell |
7,914
-1,048
| -12% | -$51.3K | 0.21% | 64 |
|
|
2015
Q4 | $452K | Hold |
8,962
| – | – | 0.24% | 67 |
|
|
2015
Q3 | $422K | Sell |
8,962
-262
| -3% | -$13.9K | 0.24% | 64 |
|
|
2015
Q2 | $501K | Hold |
9,224
| – | – | 0.25% | 67 |
|
|
2015
Q1 | $506K | Hold |
9,224
| – | – | 0.25% | 71 |
|
|
2014
Q4 | $500K | Hold |
9,224
| – | – | 0.25% | 70 |
|
|
2014
Q3 | $522K | Sell |
9,224
-367
| -4% | -$20.6K | 0.27% | 70 |
|
|
2014
Q2 | $529K | Sell |
9,591
-524
| -5% | -$28.6K | 0.28% | 73 |
|
|
2014
Q1 | $548K | Sell |
10,115
-1,310
| -11% | -$67.8K | 0.28% | 78 |
|
|
2013
Q4 | $546K | Sell |
11,425
-467
| -4% | -$21.3K | 0.29% | 74 |
|
|
2013
Q3 | $540K | Sell |
11,892
-408
| -3% | -$18.6K | 0.31% | 73 |
|
|
2013
Q2 | $545K | Buy |
+12,300
| New | +$549K | 0.32% | 72 |
|
Other funds holding MRK
Carderock Capital Management's MRK Position: Q3 2025 in Review
Carderock Capital Management sold out of Merck (MRK) in Q3 2025, closing a stake of 800 shares — an estimated $63.3K sold.
Carderock Capital Management first reported a position in MRK in Q2 2013 and held it in 36 quarters. The position peaked at $548K in Q1 2014. 3,309 funds tracked by Wall St. Rank hold MRK as of Q3 2025.
- Carderock Capital Management reported no remaining Merck position as of Q3 2025 after selling out during the quarter.
- Carderock Capital Management sold 800 Merck shares in Q3 2025, an estimated $63.3K.
- Carderock Capital Management first reported a position in Merck in Q2 2013 and held it in 36 quarters.
- Carderock Capital Management's Merck position peaked at $548K in Q1 2014.
- 3,309 funds tracked by Wall St. Rank held Merck as of Q3 2025.
Based on Carderock Capital Management's 13F filing for Q3 2025, filed 17 Oct 2025.